Skip to main content
. 2018 Oct 30;17(1):57–62. doi: 10.3892/etm.2018.6900

Figure 2.

Figure 2.

Comparison of serum levels of (A) IL-1, (B) hs-CRP, (C) TNF-α and (D) IL-8 between patients with MS and the control group. The serum levels were measured by ELISA and found to be significantly higher in patients with MS compared with the normal controls. *P<0.05. C, healthy controls; MS, metabolic syndrome; IL, interleukin; hs-CRP, high sensitivity C-reactive protein; TNF-α, tumor necrosis factor α.